HIC
NVS icon

Hartline Investment Corp’s Novartis NVS Stock Holding History

Hartline Investment Corp’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,685
Closed -$356K – 321
2024
Q1 		$356K Buy
+3,685
New +$378K 0.06% 262
2022
Q4 		– Sell
-3,205
Closed -$244K – 168
2022
Q3 		$244K Buy
+3,205
New +$266K 0.2% 115

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CCM
Cullen Capital Management New York $9.75B AUM 21.81% 1-Year Est. Return

Hartline Investment Corp's NVS Position: Q2 2024 in Review

Hartline Investment Corp sold out of Novartis (NVS) in Q2 2024, closing a stake of 3,685 shares — an estimated $356K sold.

Hartline Investment Corp first reported a position in NVS in Q3 2022 and held it in 2 quarters. The position peaked at $356K in Q1 2024. 1,306 funds tracked by Wall St. Rank hold NVS as of Q2 2024.

  • Hartline Investment Corp reported no remaining Novartis position as of Q2 2024 after selling out during the quarter.
  • Hartline Investment Corp sold 3,685 Novartis shares in Q2 2024, an estimated $356K.
  • Hartline Investment Corp first reported a position in Novartis in Q3 2022 and held it in 2 quarters.
  • Hartline Investment Corp's Novartis position peaked at $356K in Q1 2024.
  • 1,306 funds tracked by Wall St. Rank held Novartis as of Q2 2024.

Based on Hartline Investment Corp's 13F filing for Q2 2024, filed 9 Aug 2024.